Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Endocrinology|March 29, 2008
Mechanisms of glucocorticoid-induced myopathyO Schakman, H Gilson, J P Thissen
Hormone Research|November 27, 2009
Mechanisms of muscle atrophy induced by glucocorticoidsO Schakman, H Gilson, S Kalista, et al.
Pflugers Archiv : European Journal of Physiology|October 29, 2013
Myosin light chain kinase controls voltage-dependent calcium channels in vascular smooth muscleA Martinsen, O Schakman, X Yerna, et al.
The International Journal of Biochemistry & Cell Biology|June 29, 2013
Glucocorticoid-induced skeletal muscle atrophyO Schakman, S Kalista, C Barbé, et al.
Endocrinology|May 10, 2008
Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated ratsO Schakman, S Kalista, L Bertrand, et al.
Molecular Psychiatry|December 20, 2017
Neural progenitor fate decision defects, cortical hypoplasia and behavioral impairment in Celsr1-deficient miceC Boucherie, C Boutin, Y Jossin, et al.
Gene Therapy|December 17, 2009
Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopyC Baligand, H Gilson, J C Ménard, et al.
Endocrinology|November 17, 2011
The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophyS Kalista, O Schakman, H Gilson, et al.
Endocrinology|October 14, 2006
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophyH Gilson, O Schakman, L Combaret, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 29, 2012
Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammationO Schakman, M Dehoux, S Bouchuari, et al.
Pageof 2